Otolaryngology - Head and Neck Surgery·Chicago, IL

University of Chicago

Signal lift7%49%+42 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
243–274
p10 – p90
Sample N
338
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.9%
3 of 79 applicants
01Cohort funnelthis cycle
N = 338
Applied
338
100.0%
Invited
79
23.4%
Class size
3
0.9%
02Away rotation impact
+78pp lift
Non-rotators
22%
74 of 333
Rotators
100%
5 of 5
Interview lift
+78pp
vs not rotating

Of 5 prior-cycle rotators, 100% got an interview vs 22% for the wider applicant pool here. Rotation appears to materially shift interview odds at this program.

J-1 visaH-1B visaF-1 visaCategorical
Your fitUniversity of Chicago Program

Create a free profile to see your personalized fit

Get started
Contact
FB
Program Director
Fuad Michel Baroody, MD
Email director
SG
Program Coordinator
Sabrina Guerrero, BS
Email coordinator
Training sites2 hospitals
  • 1
    University of Chicago Medical Center
    Chicago, IL
    Primary
  • 2
    Evanston Hospital-Northshore University Health System
    Evanston, IL
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK243274
180205230255280

Level 2 CE data not available

Interview rates
US MD
26%
US DO
0%
US IMG
17%
Non-US IMG
0%
Applicant origin
In-state
52%
Out-of-state
21%
Interview prepOtolaryngology - Head and Neck Surgery
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add University of Chicago to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Otolaryngology - Head and Neck Surgery.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.